Candidiasis - Pipeline Review, H2 2015

Published: October 2015
No. of Pages: 140
   

Global Markets Direct’s, ‘Candidiasis Pipeline Review, H2 2015’, provides an overview of the Candidiasis’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Candidiasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Candidiasis and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope


  • The report provides a snapshot of the global therapeutic landscape of Candidiasis
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Candidiasis and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Candidiasis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Candidiasis pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products

Reasons to buy


  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Candidiasis
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Candidiasis pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Candidiasis - Pipeline Review, H2 2015

Table of Contents

Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Global Markets Direct Report Coverage 7
Candidiasis Overview 8
Therapeutics Development 9
Pipeline Products for Candidiasis - Overview 9
Pipeline Products for Candidiasis - Comparative Analysis 10
Candidiasis - Therapeutics under Development by Companies 11
Candidiasis - Therapeutics under Investigation by Universities/Institutes 13
Candidiasis - Pipeline Products Glance 14
Late Stage Products 14
Clinical Stage Products 15
Early Stage Products 16
Unknown Stage Products 17
Candidiasis - Products under Development by Companies 18
Candidiasis - Products under Investigation by Universities/Institutes 21
Candidiasis - Companies Involved in Therapeutics Development 22
Aureogen Biosciences, Inc. 22
Bakker Medical Srl 23
Biomar Microbial Technologies 24
Cellceutix Corporation 25
Cidara Therapeutics, Inc. 26
Daewoong Pharmaceutical Co., Ltd. 27
Eisai Co., Ltd. 28
General Biologicals Corporation 29
GlaxoSmithKline Plc 30
Grupo Ferrer Internacional, S.A. 31
Hsiri Therapeutics, LLC 32
iCo Therapeutics Inc. 33
Nanomerics Ltd 34
Novabiotics Limited 35
NovaDigm Therapeutics, Inc. 36
Onxeo SA 37
Panacela Labs, Inc. 38
Scynexis, Inc. 39
Sealife PHARMA GMBH 40
Sequella, Inc. 41
Viamet Pharmaceuticals, Inc. 42
Wellstat Vaccines, LLC 43
Candidiasis - Therapeutics Assessment 44
Assessment by Monotherapy Products 44
Assessment by Target 45
Assessment by Mechanism of Action 47
Assessment by Route of Administration 49
Assessment by Molecule Type 51
Drug Profiles 53
AC-17 - Drug Profile 53
amphotericin b - Drug Profile 54
amphotericin B - Drug Profile 55
arasertaconazole - Drug Profile 56
AUGC-10 - Drug Profile 57
AUGC-15 - Drug Profile 58
candida vaccine - Drug Profile 59
candida vaccine - Drug Profile 60
candidiasis oligosaccharide vaccine - Drug Profile 61
CD-101 - Drug Profile 62
CTIX-1502 - Drug Profile 64
DWP-06081 - Drug Profile 65
E-1210 - Drug Profile 66
E-1211 - Drug Profile 67
Forazoline A - Drug Profile 68
KSL-W - Drug Profile 69
MH-010 - Drug Profile 70
miconazole - Drug Profile 71
Monoclonal Antibodies to Target Fba for Candidiasis - Drug Profile 72
mutanobactins - Drug Profile 73
Myc-102 - Drug Profile 74
NDV-3 - Drug Profile 75
NDV-3A - Drug Profile 77
NP-339 - Drug Profile 78
obliquumol - Drug Profile 79
PAC-113 - Drug Profile 80
pegylated amphotericin B - Drug Profile 82
PMX-1408 - Drug Profile 83
PMX-1570 - Drug Profile 85
PMX-1576 - Drug Profile 86
PMX-1591 - Drug Profile 87
PMX-1625 - Drug Profile 88
PMX-519 - Drug Profile 89
PMX-70004 - Drug Profile 90
Prof-002 - Drug Profile 91
Recombinant Peptides for Oropharyngeal Candidiasis - Drug Profile 92
SCY-078 - Drug Profile 93
SLP-0901 - Drug Profile 95
SLP-0904 - Drug Profile 96
Small Molecule for Candidiasis - Drug Profile 97
Small Molecule for Fungal Infections - Drug Profile 98
Small Molecule for Systemic Candidiasis - Drug Profile 99
Small Molecules for Aspergillosis and Candidiasis - Drug Profile 100
Small Molecules for Candidiasis - Drug Profile 101
Small Molecules for Candidiasis - Drug Profile 102
Small Molecules for Candidiasis - Drug Profile 103
Small Molecules for Fungal Infections - Drug Profile 104
SQ-109 - Drug Profile 105
VT-1161 - Drug Profile 109
XELRYX-3 - Drug Profile 111
Candidiasis - Recent Pipeline Updates 112
Candidiasis - Dormant Projects 123
Candidiasis - Discontinued Products 125
Candidiasis - Product Development Milestones 126
Featured News & Press Releases 126
Appendix 135
Methodology 135
Coverage 135
Secondary Research 135
Primary Research 135
Expert Panel Validation 135
Contact Us 135
Disclaimer 136

List of Tables

Number of Products under Development for Candidiasis, H2 2015 13
Number of Products under Development for Candidiasis - Comparative Analysis, H2 2015 14
Number of Products under Development by Companies, H2 2015 16
Number of Products under Investigation by Universities/Institutes, H2 2015 17
Comparative Analysis by Late Stage Development, H2 2015 18
Comparative Analysis by Clinical Stage Development, H2 2015 19
Comparative Analysis by Early Stage Development, H2 2015 20
Comparative Analysis by Unknown Stage Development, H2 2015 21
Products under Development by Companies, H2 2015 22
Products under Development by Companies, H2 2015 (Contd..1) 23
Products under Development by Companies, H2 2015 (Contd..2) 24
Products under Investigation by Universities/Institutes, H2 2015 25
Candidiasis - Pipeline by Aureogen Biosciences, Inc., H2 2015 26
Candidiasis - Pipeline by Bakker Medical Srl, H2 2015 27
Candidiasis - Pipeline by Biomar Microbial Technologies, H2 2015 28
Candidiasis - Pipeline by Cellceutix Corporation, H2 2015 29
Candidiasis - Pipeline by Cidara Therapeutics, Inc., H2 2015 30
Candidiasis - Pipeline by Daewoong Pharmaceutical Co., Ltd., H2 2015 31
Candidiasis - Pipeline by Eisai Co., Ltd., H2 2015 32
Candidiasis - Pipeline by General Biologicals Corporation, H2 2015 33
Candidiasis - Pipeline by GlaxoSmithKline Plc, H2 2015 34
Candidiasis - Pipeline by Grupo Ferrer Internacional, S.A., H2 2015 35
Candidiasis - Pipeline by Hsiri Therapeutics, LLC, H2 2015 36
Candidiasis - Pipeline by iCo Therapeutics Inc., H2 2015 37
Candidiasis - Pipeline by Nanomerics Ltd, H2 2015 38
Candidiasis - Pipeline by Novabiotics Limited, H2 2015 39
Candidiasis - Pipeline by NovaDigm Therapeutics, Inc., H2 2015 40
Candidiasis - Pipeline by Onxeo SA, H2 2015 41
Candidiasis - Pipeline by Panacela Labs, Inc., H2 2015 42
Candidiasis - Pipeline by Scynexis, Inc., H2 2015 43
Candidiasis - Pipeline by Sealife PHARMA GMBH, H2 2015 44
Candidiasis - Pipeline by Sequella, Inc., H2 2015 45
Candidiasis - Pipeline by Viamet Pharmaceuticals, Inc., H2 2015 46
Candidiasis - Pipeline by Wellstat Vaccines, LLC, H2 2015 47
Assessment by Monotherapy Products, H2 2015 48
Number of Products by Stage and Target, H2 2015 50
Number of Products by Stage and Mechanism of Action, H2 2015 52
Number of Products by Stage and Route of Administration, H2 2015 54
Number of Products by Stage and Molecule Type, H2 2015 56
Candidiasis Therapeutics - Recent Pipeline Updates, H2 2015 116
Candidiasis - Dormant Projects, H2 2015 127
Candidiasis - Dormant Projects (Contd..2), H2 2015 128
Candidiasis - Discontinued Products, H2 2015 129

List of Figures

Number of Products under Development for Candidiasis, H2 2015 13
Number of Products under Development for Candidiasis - Comparative Analysis, H2 2015 14
Number of Products under Development by Companies, H2 2015 15
Number of Products under Investigation by Universities/Institutes, H2 2015 17
Comparative Analysis by Clinical Stage Development, H2 2015 19
Comparative Analysis by Early Stage Products, H2 2015 20
Assessment by Monotherapy Products, H2 2015 48
Number of Products by Top 10 Targets, H2 2015 49
Number of Products by Stage and Top 10 Targets, H2 2015 49
Number of Products by Top 10 Mechanism of Actions, H2 2015 51
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2015 51
Number of Products by Top 10 Routes of Administration, H2 2015 53
Number of Products by Stage and Top 10 Routes of Administration, H2 2015 53
Number of Products by Top 10 Molecule Types, H2 2015 55
Number of Products by Stage and Top 10 Molecule Types, H2 2015 55

Published By: Global Markets Direct
Product Code: Global Markets Direct13297


Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and we�ll share relevant market report titles for you to explore.

Related Reports:


Why ReportsnReports.com?

  • 500,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Pharmaceuticals market as per your needs. Get the best of Pharmaceuticals research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Email Alerts

Get Email alerts about market research reports from industries and publishers of your interest: